Voxelotor is a first-in-class HbS polymerization inhibitor that directly increases Hb by inhibiting the root cause of SCD—polymerization of deoxygenated HbS—thereby reducing red blood cell (RBC) destruction. This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.